These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17467641)

  • 1. Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia.
    Napolitano C; Priori SG
    Heart Rhythm; 2007 May; 4(5):675-8. PubMed ID: 17467641
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the rhythm: ventricular or supraventricular?
    Siddique SM; Hoang NT
    Heart Rhythm; 2007 Feb; 4(2):239-41. PubMed ID: 17275766
    [No Abstract]   [Full Text] [Related]  

  • 3. Catecholaminergic polymorphic ventricular tachycardia.
    Leenhardt A; Denjoy I; Guicheney P
    Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):1044-52. PubMed ID: 23022705
    [No Abstract]   [Full Text] [Related]  

  • 4. Supraventricular tachycardia versus ventricular tachycardia detection: is the device right?
    Kowalski M; Wood MA; Ellenbogen KA
    Heart Rhythm; 2009 Jan; 6(1):135-7. PubMed ID: 18838307
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia.
    Wangüemert F; Bosch Calero C; Pérez C; Campuzano O; Beltran-Alvarez P; Scornik FS; Iglesias A; Berne P; Allegue C; Ruiz Hernandez PM; Brugada J; Pérez GJ; Brugada R
    Heart Rhythm; 2015 Jul; 12(7):1636-43. PubMed ID: 25814417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deadly proposal: a case of catecholaminergic polymorphic ventricular tachycardia.
    Heiner JD; Bullard-Berent JH; Inbar S
    Pediatr Emerg Care; 2011 Nov; 27(11):1065-8. PubMed ID: 22068070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the diagnosis and management of Catecholaminergic Polymorphic Ventricular Tachycardia.
    Pflaumer A; Davis AM
    Heart Lung Circ; 2012 Feb; 21(2):96-100. PubMed ID: 22119737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia.
    Roston TM; Cunningham TC; Sanatani S
    Cardiol Young; 2017 Jan; 27(S1):S49-S56. PubMed ID: 28084961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiology update--I].
    Trappe HJ; Pfitzner P
    Med Klin (Munich); 1996 Apr; 91 Suppl 1():118-27. PubMed ID: 8657078
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of asymptomatic catecholaminergic polymorphic ventricular tachycardia.
    Obeyesekere MN; Sy RW; Leong-Sit P; Gula LJ; Yee R; Skanes AC; Klein GJ; Krahn AD
    Future Cardiol; 2012 May; 8(3):439-50. PubMed ID: 22642633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Update on the Diagnosis and Management of Catecholaminergic Polymorphic Ventricular Tachycardia.
    Pflaumer A; Davis AM
    Heart Lung Circ; 2019 Mar; 28(3):366-369. PubMed ID: 30446242
    [No Abstract]   [Full Text] [Related]  

  • 12. Sudden cardiac death despite an implantable cardioverter-defibrillator in a young female with catecholaminergic ventricular tachycardia.
    Mohamed U; Gollob MH; Gow RM; Krahn AD
    Heart Rhythm; 2006 Dec; 3(12):1486-9. PubMed ID: 17161793
    [No Abstract]   [Full Text] [Related]  

  • 13. A classic electrocardiographic manifestation of catecholaminergic polymorphic ventricular tachycardia.
    Richter S; Gebauer R; Hindricks G; Brugada P
    J Cardiovasc Electrophysiol; 2012 May; 23(5):560. PubMed ID: 21806698
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimal programming of implantable cardiac-defibrillators.
    Madhavan M; Friedman PA
    Circulation; 2013 Aug; 128(6):659-72. PubMed ID: 23918187
    [No Abstract]   [Full Text] [Related]  

  • 15. Discrimination of ventricular tachycardia from supraventricular tachycardia in implantable cardioverter defibrillators by automated electrogram morphology analysis: can leads finally replace the electrophysiologist?
    Grönefeld GC
    Europace; 2008 Oct; 10(10):1131-2. PubMed ID: 18815188
    [No Abstract]   [Full Text] [Related]  

  • 16. What is this wide-complex tachycardia and what needs to be done about it?
    Thompson C; Tsiperfal A
    Prog Cardiovasc Nurs; 2001; 16(4):176-7. PubMed ID: 11684911
    [No Abstract]   [Full Text] [Related]  

  • 17. Overcoming the defects of a virtue: dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Sweeney MO
    Circulation; 2006 Jun; 113(25):2862-4. PubMed ID: 16801472
    [No Abstract]   [Full Text] [Related]  

  • 18. Inappropriate detection and therapy from an implantable cardioverter defibrillator due to atrial undersensing.
    Paraskevaidis S; Polymeropoulos K; Vassilikos V; Louridas G
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):1002-4. PubMed ID: 16176546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholaminergic polymorphic ventricular tachycardia: important messages from case reports.
    van der Werf C; Wilde AA
    Europace; 2011 Jan; 13(1):11-3. PubMed ID: 20851823
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonpharmacologic therapy of tachyarrhythmias.
    Berns E
    Compr Ther; 1994; 20(3):162-9. PubMed ID: 8187457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.